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Neurologic Complications and Outcomes of Pandemic (H1N1) 
2009 in Korean Children 
Neurologic complications of children with influenza A H1N1 2009 pandemic, diagnosed in 
two consecutive influenza seasons were retrospectively reviewed to seek better outcomes 
in future outbreaks. Patient demographics, clinical manifestations and neurologic 
outcomes were reviewed. A total of 1,389 children were diagnosed with influenza A H1N1 
by real-time reverse transcriptase-polymerase chain reaction. Of these, 23 (1.7%) patients 
had neurologic involvement. Their mean age was 5.9 ± 3.6 yr (range, 6 months to 11 yr) 
and 16 (69.9%) were boys. None of the 23 patients had been vaccinated for influenza A 
H1N1 and seasonal influenzas. Twenty-two of the 23 patients presented with seizures. 
Clinical features included febrile convulsion (n = 19), afebrile convulsion (n = 1), aseptic 
meningitis (n = 1), encephalopathy (n = 1), and acute necrotizing encephalopathy (n = 1). 
They all were treated with Oseltamivir twice daily for 5 days immediately after nasal and 
throat swab testing. Twenty-one of the subjects recovered fully, but the youngest two 
infants experienced severe neurological sequelae. The results indicate that neurologic 
complications associated with influenza A H1N1 2009 pandemic were mostly mild, but 
rarely were serious. Prompt intervention leads to a better outcome and vaccination may 
prevent the disease, thus staving off serious neurological complications following 
influenza, especially in young infants. 
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INTRODUCTION
The pandemic (H1N1) 2009 caused by a novel influenza A H1N1 
virus (hereafter abbreviated as H1N1), which originated in the 
Mexican town of La Gloria, Veracruz, in February of that year, 
spread rapidly in Korea after being introduced in the country in 
April, 2009. The World Health Organization (WHO) declared 
the pandemic over on August 10, 2010. At that time, the death 
toll exceeded 18,000 (1). During the pandemic, on November 3, 
2009, the Korean government raised the national disaster phase 
from “alert” to “severe (red)” and the Korean Center for Disease 
Control and Prevention (KCDC) reported peak H1N1 outbreak 
from November 15 to December 5, 2009. During this time, ap-
proximately 800,000 Koreans were infected and 252 people died 
due to the H1N1 (2).
  In the aftermath of the pandemic (H1N1) 2009, much atten-
tion has been focused on the respiratory manifestations of H1N1 
(3, 4). Influenza is a major cause of acute respiratory tract illnesses 
each winter. Influenza virus infection also causes extrapulmo-
nary symptoms that include gastrointestinal or neurological 
symptoms. However, much less is known regarding neurologic 
complications. Seasonal influenza A and B viruses have varying 
degrees of neurovirulence (5) and can cause a variety of neuro-
logic complications including Reye syndrome, Guillian-Barre 
syndrome, transverse myelitis, encephalopathy, aseptic menin-
gitis, acute disseminated encephalomyelitis (ADEM), acute nec-
rotizing encephalopathy (ANE) and seizures (6, 7). Seizures are 
the most frequently reported neurologic complication and, in 
young patients, most of these manifest as febrile convulsion (8). 
Several investigators reported frequent and severe encephalop-
athy related to seasonal influenza in the past decade (9, 10). Sev-
eral studies have suggested that the pandemic (H1N1) 2009 also 
causes influenza encephalopathy in children (1, 8) and is asso-
ciated with a notable predominance of disease burden and mor-
tality in children (11).
  It is a descriptive analysis of clinical findings from a single in-
stitution. We reviewed the demographic characteristics, clinical 
features and severity of disease of affected patients focusing on 
neurologic complications for two consecutive cold seasons from 
September 2009 to March 2011. The goal was to seek manage-
ment strategies that yield a better neurologic outcome.
MATERIALS AND METHODS
Twenty-three Korean children diagnosed with pandemic (H1N1) 
2009 were retrospectively evaluated for neurological complica-Kwon S, et al.  •  Neurologic Prognosis of H1N1 in Children 
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tions at the Department of Pediatrics in Kyungpook National 
University Hospital, Daegu, Korea, during the influenza seasons 
2009-2010, and 2010-2011. Diagnoses were confirmed by nasal 
and throat swabs with the use of real-time reverse transcription-
polymerase chain reaction (RT-PCR) assay.
Case finding and data collection
We reviewed the laboratory surveillance data of our hospital 
and 1,389 cases were identified among 3,421 patients treated in 
the pediatric department using virology laboratory records that 
indicated positive findings for influenza A H1N1. The medical 
records of the identified patients were reviewed for evidence of 
neurologic complications, including febrile or non febrile sei-
zures, encephalopathy or altered mental status, meningitis and 
other neurologic complications.
Inclusion and exclusion criteria
The aforementioned cases of laboratory confirmed H1N1 were 
included. Children with an abnormal neurodevelopmental back-
ground and who did not exhibit any change from their baseline 
neurologic condition or were defined as disease of central ner-
vous system were excluded. 
Clinical data
A detailed chart review was performed for the 23 patients who 
had neurologic complications. Data on several clinical variables 
were retrieved, including age, gender, birth history, developmen-
tal history, family history, medical background, chief neurolog-
ic complications, laboratory (blood and cerebrospinal fluid) 
findings, neuroimaging and electroencephalographic findings, 
treatment and clinical outcomes. We classified the patients ac-
cording to the neurologic outcome as excellent, good, fair or 
poor. 
Study definitions
The following outcome definitions were used. In an excellent 
outcome, patients showed complete resolution. In a good out-
come, patients showed almost complete resolution or minimal 
degree of neurological sequelae (mobile, almost no cognitive/
social/emotional impairment). In a fair outcome, patients showed 
moderate degree of neurological sequelae (mobile with diffi-
culty, mild to moderate cognitive/social/emotional impairment). 
In a poor outcome, patients showed severe degree of neurologi-
cal sequelae (immobile, severe cognitive/social/emotional im-
pairment). The definition of lymphopenia in this study was a 
lymphocyte count less than 13 percent of the total number of 
leukocytes.
Statistical analysis 
Statistical analysis was performed using PASW statistical soft-
ware, version 18.0 (IBM, Somers, NY, USA). Average compari-
sons between the two groups according to prognosis, excellent 
and poor were assessed using the Mann-Whitney U test or t-test. 
Ethics statement
This study was approved by the institutional review board for 
clinical research at Kyungpook National University Hospital 
(2011-11-009). This study was retrospective analysis of the med-
ical records and so the requirement for individual patient con-
sent was waived.
RESULTS
From September 2009 to March 2010, 3,019 Korean children 
aged 6 months to 11 yr were PCR-tested for H1N1. Of these, 1,326 
were positive. From September 2010 to March 2011, 63 patients 
were positive among 402 children tested. A total of 1,389 chil-
dren were confirmed with H1N1. Of these, 23 (1.7%) of them 
had neurological involvement (Fig. 1). H1N1-related neurologic 
complications noted in 23 patients included febrile convulsion 
(n = 19), afebrile convulsion (n = 1), aseptic meningitis (n = 1), 
encephalopathy (n = 1) and acute necrotizing encephalopathy 
(n = 1). Their mean age of the 16 males and seven females was 
5.9 ± 3.6 yr (6 months to 11 yr, range). The mean age of febrile 
convulsion was 6.4 ± 3.3 yr (1.9 to 11 yr, range), while the age for 
afebrile convulsion, aseptic meningitis, acute necrotizing enceph-
alopathy and encephalopathy was 2.3 yr, 9.7 yr, 9 months, and  
6 months, respectively (Table 1). None of the patients had been 
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Fig. 1. Incidence and percentage of influenza A H1N1 PCR and neurologic complica-
tions. During the 2009-2010 influenza season, 3,019 children were PCR-tested for 
influenza A H1N1. Of these, 1,326 (43.9%) were positive and 20 patients (1.5%) had 
neurologic complications. From September 2010 to March 2011, 63 patients (15.7%) 
were positive among 402 children and three patients (4.7%) experienced neurologic 
complications. A total of 1,389 children were confirmed with influenza A H1N1;           
23 (1.7%) of them had neurological involvement.Kwon S, et al.  •  Neurologic Prognosis of H1N1 in Children 
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vaccinated for H1N1 or seasonal influenza. 
  Of the 23 patients, 22 presented with seizures (20 febrile con-
vulsion, two afebrile convulsion). Six children experienced sta-
tus epilepticus and one suffered from refractory status epilepti-
cus. Among the 20 patients with febrile convulsion, nine had 
simple febrile convulsion and the other 11 patients were  > 5 yr 
of age. Four children previously experienced febrile convulsion 
and 13 patients displayed respiratory symptoms such as cough, 
rhinorrhea or sore throat.
  Blood laboratory results were basically unremarkable, but   
13 patients showed lymphopenia and one patient displayed el-
evated serum aminotransferase. Cerebrospinal fluid analysis 
was performed in 14 children; only one showed pleocytosis. 
This patient was confirmed with aseptic meningitis and recov-
ered fully. Neuroimaging by brain magnetic resonance imaging 
(MRI) or computed tomography (CT) was done in 10 patients. 
Of these, two had abnormal findings in the corpus callosum or 
both thalami. The former was diagnosed with febrile convul-
sion and fully recuperated without neurologic deficit, but the 
latter was diagnosed with acute necrotizing encephalopathy 
and had a poor neurologic outcome. An electroencephalogram 
was done in 18 patients. The results from three patients were 
abnormal. Two patients who displayed epileptiform discharges 
were diagnosed with febrile convulsion and recovered fully after 
6 months of onset without following seizures. The other patient 
who had a diffuse, marked suppression of background activities 
was diagnosed with encephalopathy and died after 4 months of 
mechanical ventilation (Table 2). 
  All patients were treated with Oseltamivir twice daily for 5 days 
immediately after nasal and throat swab testing. Eleven chil-
dren additionally received lorazepam, phenytoin, phenobarbi-
tal or midazolam continuous drip for seizures. Twenty one pa-
tients fully recovered and were discharged. The youngest two 
patients experienced severe neurological sequelae and one of 
them died.
  We classified the patients according to the neurologic out-
come (excellent, good, fair or poor). When compared between 
the group of excellent and poor outcomes, there were statisti-
cally significant differences in age, blood potassium, percent-
ages of polymorphonuclear leukocytes and lymphocytes and 
in the hemoglobin level (Table 3).
  Two cases that presented poor neurologic outcome are de-
scribed here in more detail. In the youngest case, a 6-month-
old male infant had a flu-like illness and febrile status epilepti-
cus. Brain MRI revealed increased signal density on T2-weight-
ed imaging in the bilateral thalami and subcortical white matter 
(Fig. 2A). The findings were compatible with acute necrotizing 
encephalopathy. The patient was positive for H1N1 and was 
treated with oral Oseltamivir, solumedrol pulse therapy and in-
travenous immunoglobulin (1 g/kg/day) for 2 days. Follow-up 
MRI showed increased signal density on T2-weighted imaging 
at the same area (Fig. 2B). The patient was left with moderate 
degree neurologic sequelae showing quadriparesis with cogni-
tive impairment. 
  In the other case, a 9-month-old female infant presented 
with a 2-day history of cough, prolonged afebrile generalized 
tonic-clonic seizures and respiratory arrest. Chest X-ray and CT 
revealed bilateral pneumonic consolidation. The patient was 
Table 1. Demographic and clinical characteristics of 23 patients with neurological 
complications due to the pandemic (H1N1) 2009
Parameters No. of patients (%)
Gender
   Male
   Female
 
 16 (69.6)
   7 (30.4) 
Age (months)
   Mean ± SD 71 ± 43 (6-132)
Neurologic presentation
   Headache
   Febrile seizure
   Non febrile seizure
   Altered consciousness
 
 1 (4.4)
 19 (82.6)
 2 (8.7)
 2 (8.7)
Diagnosis
   Febrile convulsion
   Afebrile convulsion
   Aseptic meningitis
   Acute necrotizing encephalopathy
   Encephalopathy
 
 19 (82.4)
 1 (4.4)
 1 (4.4)
 1 (4.4)
 1 (4.4)
Neurologic outcome
   Excellent
   Good
   Fair
   Poor
  
 21 (91.3)
                  0
                  0
 2 (8.7)
Table 2. Neuroimaging, electroencephalogram (EEG) findings and cerebrospinal fluid 
(CSF) study of 23 patients with neurological complications due to the pandemic (H1N1) 
2009
Findings
No. (%) of patients by
Neuroimaging EEG CSF study
Abnormal Increased signal  
density in corpus  
callosum  
1 (4.4)
Increased signal  
density in both  
thalami 1 (4.4)
Epileptiform  
discharge  
2 (8.8)
Marked  
suppression  
1 (4.4)
Pleocytosis  
  1 (4.4)
Normal   8 (34.8) 15 (65.2)   13 (56.5)
Not done 13 (56.5)   5 (21.7)     9 (39.1)
Table 3. Comparison of laboratory data between patients with excellent and poor 
prognosis
 Variables
 Excellent prognosis 
 (n = 21)
 Poor prognosis 
 (n = 2)
 P value
Age (month)    76.57 ± 40.13      7.50 ± 2.12 0.027
Hb (g/dL)  12.23 ± 0.81    10.85 ± 1.20 0.037
WBC (/µL)   9,391.90 ± 4146.70 11,460.00 ± 282.80 0.497
Lymphocytes (%)    9.43 ± 4.12    33.00 ± 1.41 < 0.001
AST (U/L)    32.00 ± 15.10      213.00 ± 240.40 0.480
ALT (U/L)  15.57 ± 3.67      101.00 ± 103.20 0.452
K (mM/L)    4.10 ± 0.44      5.05 ± 0.07 0.007Kwon S, et al.  •  Neurologic Prognosis of H1N1 in Children 
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also positive for H1N1 and was treated with oral oseltamivir, in-
travenous cefotaxime, ampicillin and dexamethasone for pre-
sumed encephalopathy. The patient remained comatose, re-
quired mechanical ventilation for 4 months and ultimately died.
 
DISCUSSION
The present study was conducted to evaluate the clinical features 
in Korean children aged 6 months to 11 yr who visited a single 
institution during influenza seasons 2009-2010, and 2010-2011.
  In Korea, much attention has been paid to H1N1 in the after-
math of the 2009 illness outbreak (12, 13), but little is known re-
garding H1N1-related neurologic complications in children. A 
few studies in Western countries have reported a wide spectrum 
of neurologic manifestations in children associated with the 
pandemic (H1N1) 2009, ranging from simple febrile convulsion 
to encephalopathy (14, 15). The reported prevalence of H1N1-
related neurological complications in children has been vari-
able, ranging from 2%-15% (14, 16). In this study, 1,389 patients 
diagnosed with H1N1 by nasal and throat swabs with the use of 
real-time RT-PCR assay were enrolled. Of these subjects, 23 chil-
dren (1.7%) had neurologic symptoms. All were hospitalized 
and two went to pediatric intensive care unit for seizure control 
and mechanical ventilation.
  Respiratory symptoms are the main clinical manifestations of 
influenza, but extrapulmonary symptoms can also occur. Sei-
zure has been reported as the most common neurologic com-
plication of seasonal influenza A and B (6, 17), as well as pan-
demic (H1N1) 2009 (8, 18), but shows good prognosis. In con-
trast, encephalopathy is rare, but it can cause a serious outcome, 
especially in patients of young age or with underlying neuromus-
cular disorder (6). In the present study, consistent with other 
studies, seizure was the most common neurologic complica-
tion, occurring in 22 of the 23 children displaying neurologic 
symptoms. Twenty children had febrile seizures; nine of them 
were older than 5 yr of age, these nine patients were not consid-
ered as high risk for febrile convulsions. Influenza-induced fe-
brile or non-febrile seizures might be associated with the devel-
opment of epilepsy (19). However, further evaluation and long-
term follow-up is required to confirm this relationship. Com-
pared with seasonal influenza, H1N1 is not more severe, but 
neurologic complications such as encephalopathy, focal neu-
rologic sign, aphasia and abnormal electroencephalogram find-
ings can be more common (11, 20). Neurologic complications 
resulting from H1N1 in pediatric populations include various 
clinical manifestations such as seizure, aseptic meningitis, en-
cephalitis and acute disseminated encephalomyelitis and can 
result in significant acute and residual neurologic sequelae (14, 
18). During influenza season, pediatricians should consider in-
fluenza as the cause of unexplained mental status change, espe-
cially in a patient with an underlying chronic illness, because of 
more aggressive clinical course. The incidence of neurologic com-
plications are more common in patients who require intensive 
care (16%-20%), with common symptoms being seizure (6%), 
encephalopathy (12%), encephalitis (1%) and myositis (1%) (21).
  Neurologic complications in this study included febrile or 
afebrile convulsion, aseptic meningitis and encephalopathy. 
The outcome of these neurologic complications ranged from 
spontaneous resolution without sequelae to encephalopathy. 
With respect to prognosis, a younger age could prelude a poor-
Fig. 2. Brain MRI of the patient with acute necrotizing encephalopathy. (A) Initial T2-weighted image shows a high signal intensity lesion (arrows) in both thalami. (B) Follow-up 
brain MRI reveals bilateral symmetric hyperintense lesions (arrows) in the both thalami on T2-weighted image.
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er outcome; the two youngest patients had moderate to severe 
sequelae after H1N1 infection. However, immediate and thor-
ough evaluation and aggressive management often produced a 
good clinical outcome. 
  Although some insist age does not affect the clinical result 
(22), it is generally accepted that younger individuals are more 
vulnerable to severe influenza; this supposition is supported  
by the present results. Influenza vaccination for infants over             
6 months of age could be prudent in reducing severe infections 
(23). For seasonal influenza, underlying medical conditions 
such as chronic lung disease, heart disease, immunodeficiency, 
metabolic disease and specific age group (> 64 yr of age,  < 2 yr 
of age) are risk factors for severe influenza (11). Patients with 
these specific medical conditions have higher rates of hospital-
ization and death (24, 25). Also presently, no patient had high 
risk factors for severe influenza, with the exception of young 
age (< 2 yr of age). Lymphopenia has been implicated as a major 
risk factor (26); however, this was not presently apparent. It 
seemed that a thorough investigation might be helpful in plan-
ning treatment strategy and predicting the clinical course. How-
ever, this assumption remains unsubstantiated because of the 
limited number of subjects, especially the group of poor prog-
nosis, in the present study.
  In the influenza season from 2010 to 2011, the number of pa-
tients suspected of having H1N1 and who were required to get 
a PCR test was markedly decreased, probably due to improved 
herd immunity from the previous symptomatic or asymptom-
atic infections and vaccinations (23). As a result, the incidence 
of neurologic complications was markedly decreased, consis-
tent with a previous report (27). 
  In conclusion, neurologic complications from the pandemic 
(H1N1) 2009 are usually mild and benign, but rarely result in 
poor neurological sequlae. Early prompt intervention leads to a 
better outcome and vaccination may prevent the disease, thus 
staving off serious neurological complications following influ-
enza, especially in young infants.
  Although this study provides useful information about neu-
rologic complications associated with H1N1, it has several limi-
tations. We did not perform comparison between the group with 
pandemic (H1N1) 2009 and the group with seasonal influenza. 
In addition, this study reports from only single institution in 
Korea, and the incidence and spectrum of disease could have 
potential selection bias.
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